Somatostatin-like immunoreactivity in CSF in schizophrenic patients during haloperidol treatment.
Jolkkonen
J
J
Vaajasalo Hospital, Kortejoki, Kuopio, Finland.
Pitkänen
A
A
Riekkinen
P J
PJ
Korpi
E R
ER
Kaufmann
C A
CA
Weinberger
D R
DR
D000328:Adult; D000368:Aged; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010455:Peptides; D012016:Reference Values; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D010455:Peptides; C029993:somatostatin-like peptides; D006220:Haloperidol